146 results on '"T, Miyamoto"'
Search Results
2. Circulating Tumor Cells and Circulating Tumor DNA in Urologic Cancers
- Author
-
Ikenna, Madueke, Richard J, Lee, and David T, Miyamoto
- Subjects
Male ,Urologic Neoplasms ,Urology ,Biomarkers, Tumor ,Liquid Biopsy ,Humans ,Neoplastic Cells, Circulating ,Circulating Tumor DNA - Abstract
Liquid biopsies such as circulating tumor cells (CTCs) and circulating tumor DNA (ctDNA) have great potential to serve as prognostic and predictive biomarkers in urologic cancers. The possibility of using liquid biopsies for real-time noninvasive and dynamic monitoring of response to therapy has been an active area of investigation. In this brief review, we outline the evidence for the potential clinical utility of CTC and ctDNA analyses in prostate, urothelial, and renal cancers.
- Published
- 2023
3. Quality and Safety Considerations in Stereotactic Radiosurgery and Stereotactic Body Radiation Therapy: An ASTRO Safety White Paper Update
- Author
-
Indra J. Das, Samantha L. Dawes, Michael M. Dominello, Brian Kavanagh, Curtis T. Miyamoto, Todd Pawlicki, Lakshmi Santanam, Yevgeniy Vinogradskiy, and Anamaria R. Yeung
- Subjects
Oncology ,Radiology, Nuclear Medicine and imaging - Published
- 2022
4. Bladder preservation: Translating discovery for clinical impact in urothelial cancer
- Author
-
Kent W. Mouw, Philip Abbosh, David T. Miyamoto, and Catharine M L West
- Subjects
Oncology ,medicine.medical_specialty ,Urology ,medicine.medical_treatment ,030232 urology & nephrology ,urologic and male genital diseases ,Article ,Bladder preservation ,Cystectomy ,03 medical and health sciences ,0302 clinical medicine ,Internal medicine ,medicine ,Humans ,Urothelial cancer ,Effective treatment ,Carcinoma, Transitional Cell ,Bladder cancer ,business.industry ,medicine.disease ,Molecular biomarkers ,female genital diseases and pregnancy complications ,Urinary Bladder Neoplasms ,030220 oncology & carcinogenesis ,Identification (biology) ,business ,Organ Sparing Treatments - Abstract
Muscle-invasive bladder cancer can be treated with either radical cystectomy or bladder preservation approaches, and there is a need for reliable biomarkers to guide the optimal choice of therapy. The recent elucidation of the genomic landscape and biological drivers of bladder cancer has enabled the identification of tumor molecular features that may be helpful in driving clinical decision-making. Here, we summarize recent efforts to develop molecular biomarkers that could be leveraged to guide therapeutic decisions, post-treatment monitoring, and the optimal use of bladder preservation approaches for the effective treatment of muscle-invasive bladder cancer.
- Published
- 2021
5. Corrigendum to 'Prognostic value of sequencing-based minimal residual disease detection in patients with multiple myeloma who underwent autologous stem-cell transplantation'
- Author
-
H. Takamatsu, N. Takezako, J. Zheng, M. Moorhead, V.E.H. Carlton, K.A. Kong, R. Murata, S. Ito, T. Miyamoto, K. Yokoyama, K. Matsue, T. Sato, T. Kurokawa, H. Yagi, Y. Terasaki, K. Ohata, M. Matsumoto, T. Yoshida, M. Faham, and S. Nakao
- Subjects
Oncology ,Hematology - Published
- 2023
6. Impact of Immune and Stromal Infiltration on Outcomes Following Bladder-Sparing Trimodality Therapy for Muscle-Invasive Bladder Cancer
- Author
-
Elai Davicioni, Chin-Lee Wu, Ewan A. Gibb, Roland Seiler, David T. Miyamoto, Felix Y. Feng, William U. Shipley, Kent W. Mouw, Peter C. Black, Jason A. Efstathiou, Marguerite du Plessis, Michael Drumm, Natalie Q. Wang, Jose Batista da Costa, and Yang Liu
- Subjects
Oncology ,medicine.medical_specialty ,Tumor microenvironment ,Stromal cell ,Bladder cancer ,business.industry ,Urology ,medicine.medical_treatment ,Hazard ratio ,030232 urology & nephrology ,medicine.disease ,Cystectomy ,Gene expression profiling ,03 medical and health sciences ,0302 clinical medicine ,030220 oncology & carcinogenesis ,Internal medicine ,Cohort ,medicine ,Biomarker (medicine) ,610 Medicine & health ,business - Abstract
Background Bladder-sparing trimodality therapy (TMT) is an alternative to radical cystectomy (RC) for muscle-invasive bladder cancer (MIBC), and biomarkers to inform therapy selection are needed. Objective To evaluate the prognostic value of immune and stromal signatures in MIBC treated with TMT. Design, setting, and participants We used a clinical-grade platform to perform transcriptome-wide gene expression profiling of primary tumors from 136 MIBC patients treated with TMT at a single institution. We observed 60 overall survival events at 5 yr, and median follow-up time for patients without an event was 5.0 yr (interquartile range 3.1, 5.0). Expression data from another cohort of 223 MIBC patients treated with neoadjuvant chemotherapy (NAC) and RC were also analyzed. Outcome measurements and statistical analysis Molecular subtype, immune, and stromal signatures were evaluated for associations with disease-specific survival (DSS) and overall survival (OS) in TMT patients, and in patients treated with NAC and RC. Results and limitations Gene expression profiling of TMT cases identified luminal (N = 40), luminal-infiltrated (N = 26), basal (N = 54), and claudin-low (N = 16) subtypes. Signatures of T-cell activation and interferon gamma signaling were associated with improved DSS in the TMT cohort (hazard ratio 0.30 [0.14–0.65], p = 0.002 for T cells), but not in the NAC and RC cohort. Conversely, a stromal signature was associated with worse DSS in the NAC and RC cohort (p = 0.006), but not in the TMT cohort. This study is limited by its retrospective nature. Conclusions Higher immune infiltration in MIBC is associated with improved DSS after TMT, whereas higher stromal infiltration is associated with shorter DSS after NAC and RC. Additional studies should be conducted to determine whether gene expression profiling can predict treatment response. Patient summary We used gene expression profiling to study the association between tumor microenvironment and outcomes following bladder preservation therapy for invasive bladder cancer. We found that outcomes varied with immune and stromal signatures within the tumor. We conclude that gene expression profiling has potential to guide treatment decisions in bladder cancer.
- Published
- 2019
7. Phase equilibria in the Ni-Mn-Sb alloy system
- Author
-
T. Miyamoto, M. Nagasako, and R. Kainuma
- Subjects
Mechanics of Materials ,Mechanical Engineering ,Materials Chemistry ,Metals and Alloys - Published
- 2019
8. Qualitative and Quantitative Analysis of a Deep Learning Auto Contouring Model for Radiotherapy in Localized Prostate Cancer
- Author
-
M.C. Kirk, G.H. Boyd, Jason A. Efstathiou, Anthony L. Zietman, Sophia C. Kamran, Yalin Wang, and David T. Miyamoto
- Subjects
Cancer Research ,Contouring ,Radiation ,business.industry ,medicine.medical_treatment ,Deep learning ,medicine.disease ,Radiation therapy ,Prostate cancer ,medicine.anatomical_structure ,Oncology ,Prostate ,medicine ,Radiology, Nuclear Medicine and imaging ,Artificial intelligence ,Nuclear medicine ,business ,Radiation treatment planning ,Quantitative analysis (chemistry) ,Radiation oncologist - Abstract
PURPOSE/OBJECTIVE(S) To evaluate a convolutional neural network auto-contouring (AC) model created for treatment planning in patients receiving radiotherapy for localized prostate cancer after insertion of a radiopaque rectal spacer hydrogel. MATERIALS/METHODS The deep learning model, trained by 125 patients, auto contours target volumes (prostate and proximal seminal vesicles), OARs (bladder, rectum, femoral heads and penile bulb) and radiopaque rectal spacers. ACs were evaluated against MD manual contours (MCs) submitted for treatment planning. ACs were not available for MD review while creating MCs. Individual volumes as well as composite volumes (overall performance) were qualitatively evaluated by a radiation oncologist using a 1 (minor discrepancy, little to no dose-volume impact), 2 (moderate discrepancy or editable with substantial efficiency gain), 3 (significant discrepancy or editable with meaningful efficiency gain), and 4 (rejected due to gross error or editable without efficiency gain) scoring scale. Quantitative evaluation of geometric differences was performed with mean distance to agreement (MDA) and Dice Similarity Coefficient (DSC) for each volume. RESULTS A total of 68 cases were evaluated by quantitative and qualitative metrics (Table 1). MCs were performed by 4 experienced MDs. Average composite score of 2.22 (SD 0.73) indicates substantial to meaningful efficiency gain in contouring process. Composite scores for 100% of cases evaluated indicate a meaningful efficiency gain in the contouring process, with 60% of composite scores indicating only minor to moderate discrepancy between contours. Prostate and SV AC average scores were above 2. Mean prostate MDA and DSC were 1.71 and 0.85, respectively, both within tolerance range recommended by AAPM TG 132. CONCLUSION The model can accurately auto contour target volumes, OARs and spacer with meaningful to substantial efficiency gain, with a majority of target volumes qualitatively evaluated by a physician as having only mild to moderate discrepancies. Quantitative analysis shows contours for most OARs have only minor geometric differences unlikely to have significant dose-volume impacts. Further analysis with comparison of treatment plans generated from ACs and MCs is warranted.
- Published
- 2021
9. Molecular biomarkers in bladder preservation therapy for muscle-invasive bladder cancer
- Author
-
William U. Shipley, Jason A. Efstathiou, David T. Miyamoto, Felix Y. Feng, and Kent W. Mouw
- Subjects
0301 basic medicine ,Oncology ,medicine.medical_specialty ,medicine.medical_treatment ,Clinical Decision-Making ,Cystectomy ,03 medical and health sciences ,0302 clinical medicine ,Predictive Value of Tests ,Risk Factors ,Internal medicine ,Biomarkers, Tumor ,medicine ,Animals ,Humans ,Neoplasm Invasiveness ,Precision Medicine ,Liquid biopsy ,Chemotherapy ,Bladder cancer ,business.industry ,Liquid Biopsy ,Immunotherapy ,medicine.disease ,Molecular Imaging ,Clinical trial ,Radiation therapy ,Treatment Outcome ,030104 developmental biology ,Molecular Diagnostic Techniques ,Urinary Bladder Neoplasms ,Chemotherapy, Adjuvant ,030220 oncology & carcinogenesis ,Predictive value of tests ,business ,Organ Sparing Treatments - Abstract
Summary Although muscle-invasive bladder cancer is commonly treated with radical cystectomy, a standard alternative is bladder preservation therapy, consisting of maximum transurethral bladder tumour resection followed by radiotherapy with concurrent chemotherapy. Although no successfully completed randomised comparisons are available, the two treatment paradigms seem to have similar long-term outcomes; however, clinicopathologic parameters can be insufficient to provide clear guidance in the selection of one treatment over the other. Recent advances in the molecular understanding of bladder cancer have led to the identification of new predictive biomarkers that ultimately might help guide the tailored selection of therapy on the basis of the intrinsic biology of the tumour. In this Review, we discuss the existing evidence for molecular alterations and genomic signatures as prognostic or predictive biomarkers for bladder preservation therapy. If validated in prospective clinical trials, such biomarkers could enable the identification of subgroups of patients who are more likely to benefit from one treatment over another, and guide the use of combination therapies that include other modalities, such as immunotherapy, which might act synergistically with radiotherapy.
- Published
- 2018
10. Adaptive Changes and Estimated Long-Term Survival After Updated Donor Heart Allocation Policy: A UNOS Database Analysis
- Author
-
T. Miyamoto, C. Pritting, D. Ahmad, Y. Brailovsky, M.K. Shah, I. Rajapreyar, J.E. Rame, R.J. Alvarez, J.W. Entwistle, H.T. Massey, and V. Tchantchaleishvili
- Subjects
Pulmonary and Respiratory Medicine ,Transplantation ,Surgery ,Cardiology and Cardiovascular Medicine - Published
- 2022
11. EFETIVIDADE, IMUNOGENICIDADE E SEGURANÇA DA MEIA DOSE DA VACINA CHADOX1 NCOV-19 CONTRA SARS-COV2 (PROJETO VIANA)
- Author
-
Valéria Valim, Maria da Penha Gomes Gouvea, Olindo Assis Martins Filho, Andrea Teixeira Carvalho, Luiz Antônio Bastos Camacho, Daniel A. Maciel Villela, Lauro Ferreira Pinto Neto, Carla Domingues, Isac Ribeiro Moulaz, Beatriz Paoli Thompson, Karen Evelin Monlevade Lança, Gabriela Curto Cristianes Lacerda, João Pedro Gonçalvez Lenzi, Sabrina de Souza Ramos, João Pedro Moraes Miossi, Matheus Leite Rassele, Felipe de Castro Pimentel, Allan Gonçalves Henriques, Maria Eduarda Moraes Hibner Amaral, Lucas Santos Silva, Laís Pasti, Gabriel Smith Sobral Vieira, Thais Luma de Oliveira Roza, Alessandro Demoner Ramos, Heitor Filipe Surlo, Luiza Lorenzoni Grillo, Laura Gonçalves Rodrigues Aguiar, Matheus Pereira Rosi, Ramon Borge Rizzi, Paula dos Santos Athayde, Pietra Zava Lorencini, Adriana Santos Silva, Tania Reuter, Jaquelini Jubini, Danielle Grillo Pacheco Lyra, Rodrigo Ribeiro Rodrigues, Cristiano Soares da Silva, Luís Carlos Reblin, Orlei Cardoso, Samira T. Miyamoto, Ketty Lysie Libardi Lira Machado, Ludimila Forechi, Carolina Strauss, Jadher Percio, Lely Stella Guzmán Barrera, Nésio Fernandes de Medeiros Junior, and José Geraldo Mill
- Subjects
Microbiology (medical) ,Infectious Diseases ,Infectious and parasitic diseases ,RC109-216 ,Microbiology ,QR1-502 - Abstract
Introdução: A escassez de insumos tem sido uma grande limitação para o avanço da vacinação. O objetivo deste estudo foi avaliar a efetividade, imunogenicidade e segurança da meia dose da ChAdOx1 nCoV-19. Métodos: Ensaio clínico controlado não randomizado de fase III com grupos de comparação interna e externa (profissionais de saúde vacinados com dose plena). Moradores de Viana-ES, 18-49 anos, receberam duas meias doses da ChAdOx1 nCoV-19, com intervalo de 8 semanas. Foram estudados a incidência novos casos, número de mortes, internações e admissões em UTI, anticorpos neutralizantes por teste de neutralização em placa (PRNT) e quimioluminescência contra a porção RBD da fração S1 da proteína Spike, anticorpos totais IgG específico para SARS-Cov2, fatores solúveis sistêmicos, imunidade celular por estimulação antígeno-específica de células mononucleares do sangue periférico in vitro e investigação de Linfócitos T e B de memória e de citocinas intracitoplasmáticas. Eventos adversos foram monitorizados por diário, registro em plataforma digital, busca ativa por telefone, notificações no E-SUS notifica. Tempos de coleta: antes, 28 dias após 1ª.(D1) e 2ª. (D2) doses, e seguimento 3,6,12 meses pós D2. Resultados: Dos 27.000 elegíveis, 20.546 indivíduos receberam duas meias doses. Desses, 572 coletaram amostras biológicas. Após D2, a taxa de soroconversão entre soronegativos no baseline (n = 239) foi 99,8% semelhante à dose plena (DP) (n = 104, 100%). A média geométrica dos títulos de anticorpos (IC95%; UA/dL) foi 1.324 (1.148-1.527) com a MD e 3.727 (2.975-4.668) com DP (p < 0,001). No subgrupo com infecção natural prévia, os títulos foram semelhantes à dose padrão, mas houve queda dos títulos após D2 comparado com D1 nos dois grupos (MD = 9.569 (8.768-10.443) vs. 5.742 (3.195-6.347)), (DP = 9.533 (7.377-12.319) vs. 4.915 (3.767-6.412)). A frequência de eventos adversos foi semelhante, mas a duração dos sintomas foi menor no grupo MD. Não ocorreram eventos adversos graves. Taxas de casos confirmados após imunização completa foi semelhante à dose plena (20/248.830 vs. 28/419.248 casos/pessoas dia). Conclusão: Meia dose da ChAdOx1 nCoV-19 é segura, imunogênica e capaz de induzir anticorpos neutralizantes em 99,8%. Em pessoas que tiveram infecção natural, uma meia dose foi semelhante a dose plena, e suficiente para induzir altos títulos de anticorpos. Resultados de imunidade celular e efetividade estão sendo analisados. Apoio: ICEPi/SESA, MS, PNI, OPAS, HUCAM, UFES, EBSERH.
- Published
- 2022
12. Molecular analysis of circulating tumors cells: Biomarkers beyond enumeration
- Author
-
David T. Miyamoto, William L. Hwang, and Haley M. Pleskow
- Subjects
0301 basic medicine ,business.industry ,Cancer therapy ,Pharmaceutical Science ,Cancer ,Computational biology ,Neoplastic Cells, Circulating ,medicine.disease ,Tumor heterogeneity ,Molecular analysis ,03 medical and health sciences ,030104 developmental biology ,0302 clinical medicine ,Circulating tumor cell ,Neoplasms ,030220 oncology & carcinogenesis ,Biomarkers, Tumor ,medicine ,Humans ,Liquid biopsy ,Early Cancer Detection ,business ,Predictive biomarker - Abstract
Advances in our molecular understanding of cancer biology have paved the way to an expanding compendium of molecularly-targeted therapies, accompanied by the urgent need for biomarkers that enable the precise selection of the most appropriate therapies for individual cancer patients. Circulating biomarkers such as circulating tumor cells (CTCs) are poised to fill this need, since they are "liquid biopsies" that can be performed non-invasively and serially, and may capture the spectrum of spatial and temporal tumor heterogeneity better than conventional tissue biopsies. Increasing evidence suggests that moving beyond the enumeration of CTCs towards more sophisticated molecular analyses can provide actionable data that may predict and potentially improve clinical outcomes. In this review, we discuss the potential of molecular CTC analyses to serve as prognostic and predictive biomarkers to guide cancer therapy and early cancer detection. As technologies to capture and analyze CTCs continue to increase in sophistication, we anticipate that the potential clinical applications of CTCs will grow exponentially in the coming years.
- Published
- 2018
13. Impact of AR-V7 and Other Androgen Receptor Splice Variant Expression on Outcomes of Post-Prostatectomy Salvage Therapy
- Author
-
Shulin Wu, Michael Drumm, David T. Miyamoto, K Otani, Chin-Lee Wu, David J. Konieczkowski, Jason A. Efstathiou, and Philip J. Saylor
- Subjects
Oncology ,Cancer Research ,medicine.medical_specialty ,Radiation ,business.industry ,Prostatectomy ,Proportional hazards model ,medicine.medical_treatment ,Salvage therapy ,medicine.disease ,Radiation therapy ,Androgen receptor ,Androgen deprivation therapy ,Prostate cancer ,Internal medicine ,Medicine ,Radiology, Nuclear Medicine and imaging ,splice ,business - Abstract
Purpose/objective(s) Radiotherapy (RT) with or without androgen deprivation therapy (ADT) plays a key role in the salvage treatment of prostate cancer recurrent after prostatectomy. However, not all patients benefit from salvage therapy, and there is an unmet need for biomarkers to distinguish responders from non-responders. Prostate cancer depends on androgen receptor (AR) signaling, and expression of AR splice variants (ARVs) that enable androgen-independent AR signaling is associated with resistance to ADT in the metastatic setting. Recent in vitro data suggest that ARVs also mediate DNA repair after irradiation, suggesting that ARV expression may also be a biomarker of resistance to RT. However, the landscape of ARV expression in primary prostate cancer and its effect on treatment outcomes remain unexplored. Here, we hypothesized that ARVs may be detectable in primary prostate cancer and furthermore may modulate response to salvage RT+ADT. Materials/methods We retrospectively identified 46 prostate cancer patients treated with prostatectomy followed by salvage RT+ ADT at a single institution from 1995 to 2012. Median age at salvage was 64.5 years. The indication for salvage therapy was biochemical failure after an undetectable post-operative PSA in 72%, gross local recurrence in 17%, and persistently elevated PSA after surgery in 11%. Median RT dose was 64.8 Gy, and all patients received concurrent ADT. We comprehensively interrogated the landscape of ARVs by performing ultra-deep targeted RNA-seq of archival formalin-fixed paraffin-embedded prostatectomy samples. Using a custom library of > 3000 primers spanning all AR exons and introns, we evaluated 21 native splice junction sites and 20 splice variants with a mean depth of coverage of > 5000x. We tested for association between splice variant expression and clinical outcomes using the log-rank test and Cox proportional hazards model. Results In total, 76% of patients had one or more detectable AR splice variants. The most commonly detected variants were AR-45 (exon 1b-2) in 41%, AR-V9 (exon 3-cryptic exon (CE) 5) in 20%, and AR-V7 (exon 3-CE3) in 13%. At a median follow-up of 33.8 months, biochemical progression-free survival (BPFS) at 3 years was 60%, distant metastasis-free survival was 90%, and overall survival was 100%. Among detected splice variants, only AR-V7 was associated with differential clinical outcomes, with a median BPFS of 10.9 months in AR-V7 positive vs 73.4 months in AR-V7 negative patients (P = 0.0020, HR 5.23, 95% CI 1.62-16.87). Conclusion Using a custom ultra-deep targeted RNA-Seq approach, we provide among the first comprehensive descriptions of the AR splice variant landscape in primary prostate cancer. Moreover, we show that detectable AR-V7 expression in prostatectomy specimens was associated with inferior outcomes following subsequent salvage RT+ADT, suggesting for the first time that AR-V7 may modulate outcomes for localized as well as metastatic disease.
- Published
- 2021
14. Circulating Tumor Cells and Radium-223 Response in Metastatic Castration-Resistant Prostate Cancer
- Author
-
David T. Miyamoto, Katherine T. Broderick, Daniel A. Haber, Shyamala Maheswaran, R. Fisher, K. Otani, R. Balza, E. Kusaka, J. Ukleja, Philip J. Saylor, and H. Pleskow
- Subjects
Radium-223 ,Cancer Research ,Radiation ,business.industry ,Castration resistant ,medicine.disease ,Prostate cancer ,Circulating tumor cell ,Oncology ,Cancer research ,medicine ,Radiology, Nuclear Medicine and imaging ,business ,medicine.drug - Published
- 2020
15. Optimization of Device Deairing and Airless Connection Techniques for Cleveland Clinic Continuous-Flow Artificial Heart
- Author
-
B. Kuban, Kiyotaka Fukamachi, Y. Kado, Jamshid H. Karimov, T. Miyamoto, J. Cang, A. Polakowski, and Shengqiang Gao
- Subjects
Pulmonary and Respiratory Medicine ,Transplantation ,business.industry ,Centrifugal pump ,medicine.disease ,Priming (steam locomotive) ,Air embolism ,law.invention ,Mandrel ,Electrical conduit ,law ,Artificial heart ,medicine ,Surgery ,Outflow ,Implant ,Cardiology and Cardiovascular Medicine ,business ,Biomedical engineering - Abstract
Purpose Prevention of air introduction during mechanical circulatory support device implant is critical for a successful outcome. A substantial amount of air may be introduced into the circulation during pump to outflow port connection, which may become detrimental for optimal pump function and long-term survival. In this study, we evaluated techniques of seamless, airless connection of double-ended centrifugal pump (continuous-flow total artificial heart [CFTAH]) in vivo. Methods The airless CFTAH connection techniques were evaluated in acute in vivo (n=2) CFTAH implants (Jersey calves, weight: 77.8 and 80.8 kg). Techniques consisted of pump priming with normal saline (Fig. 1 A) and application of specifically designed connection sleeve (Fig 1B). The silicone sleeve (0.3-0.5 mm thick) was prototyped using multilayer dip-coating technique over a 3D-printed mandrel. A suture line was added along the long axis, to enable easy removal. Deairing sleeve was pre-placed on each outflow port (conduit) and proximal port (port) ends (Fig.1 C). The present air was evacuated upward from an open line. The conduit and pump ports were connected within the sleeve (Fig.1 D), with air being fully excluded from circuit. The CFTAH was started at the minimum speed (2,200 rpm) after connection. Results The CFTAH pump were successfully primed with saline prior to implant to remove entrapped air. The completely seamless pump connection and exclusion of air from pump and outflow grafts has been found feasible. There were no clinical signs of air embolism in the pulmonary or systemic circulation observed during the experiment. Conclusion The seamless connection of CFTAH to outflow grafts using specifically designed connection sleeve and its easy removal was demonstrated to be feasible. Device development is ongoing and will aim to address optimal geometry, size and material selection.
- Published
- 2020
16. Cell-free and circulating tumor cell–based biomarkers in men with metastatic prostate cancer: Tools for real-time precision medicine?
- Author
-
David T. Miyamoto and Richard T. Lee
- Subjects
Male ,0301 basic medicine ,Oncology ,medicine.medical_specialty ,Pathology ,Urology ,Gene Dosage ,Cell free ,Adenocarcinoma ,03 medical and health sciences ,Prostate cancer ,0302 clinical medicine ,Circulating tumor cell ,Computer Systems ,Internal medicine ,Antineoplastic Combined Chemotherapy Protocols ,Biomarkers, Tumor ,medicine ,Multiple time ,Humans ,Multicenter Studies as Topic ,Precision Medicine ,Clinical Trials as Topic ,business.industry ,Prostatic Neoplasms ,DNA, Neoplasm ,Neoplastic Cells, Circulating ,Prognosis ,medicine.disease ,Precision medicine ,Peripheral blood ,Neoplasm Proteins ,Circulating biomarkers ,Treatment Outcome ,030104 developmental biology ,Receptors, Androgen ,Circulating tumor DNA ,030220 oncology & carcinogenesis ,Mutation ,Single-Cell Analysis ,business - Abstract
The recent expansion of therapeutic options for the treatment of metastatic prostate cancer highlights the need for precision medicine approaches to enable the rational selection of appropriate therapies for individual patients. In this context, circulating biomarkers in the peripheral blood are attractive as readily accessible tools for predicting and monitoring therapeutic response. In the case of circulating tumor cells and circulating tumor DNA, they may also serve as a noninvasive means of assessing molecular aberrations in tumors at multiple time points before and during therapy. These so-called "liquid biopsies" can provide a snapshot view of tumor molecular architecture and may enable clinicians to monitor the molecular status of tumors as they evolve during treatment, thus allowing for individualized precision therapeutic decisions for patients over time. In this review, we outline recent progress in the field of circulating biomarkers in metastatic prostate cancer and evaluate their potential for enabling this vision of real-time precision medicine.
- Published
- 2016
17. Mutational Landscape and Genetic Determinants of Response to Trimodality Therapy in Muscle-Invasive Bladder Cancer
- Author
-
David T. Miyamoto, Henning Willers, E.M. Van Allen, Jochen K. Lennerz, Tiffany Hong, William U. Shipley, Jason A. Efstathiou, Shulin Wu, Chin-Lee Wu, Darrell R. Borger, Sophia C. Kamran, J. Ukleja, E. Kusaka, Kent W. Mouw, and K. Otani
- Subjects
Oncology ,Cancer Research ,medicine.medical_specialty ,Radiation ,Bladder cancer ,business.industry ,Internal medicine ,Muscle invasive ,Medicine ,Radiology, Nuclear Medicine and imaging ,business ,medicine.disease - Published
- 2020
18. Disruption of adaptation in bladder capacity for urine production rate during night time in aged men with nocturia: Analysis of the data of frequency volume chart
- Author
-
T. Ihara, Norifumi Sawada, S. Kira, Masayuki Takeda, H. Nakagomi, T. Miyamoto, and Takahiko Mitsui
- Subjects
Gerontology ,medicine.medical_specialty ,Urine production ,business.industry ,Frequency volume chart ,Urology ,Medicine ,Nocturia ,Adaptation (eye) ,Bladder capacity ,medicine.symptom ,business - Published
- 2017
19. Total Artificial Heart Incorporating Novel Stacked Motor; First In Vivo Results
- Author
-
Y. Kado, Kiyotaka Fukamachi, Jamshid H. Karimov, David J. Horvath, T. Miyamoto, and Barry D. Kuban
- Subjects
Pulmonary and Respiratory Medicine ,Transplantation ,Suction ,business.industry ,Stator ,Rotor (electric) ,Atrial Pressure ,Inflow ,Volute ,law.invention ,medicine.anatomical_structure ,law ,Artificial heart ,Vascular resistance ,Medicine ,Surgery ,Cardiology and Cardiovascular Medicine ,business ,Biomedical engineering - Abstract
Purpose The latest version of the continuous flow total artificial heart (CFTAH), which incorporates a novel stacked motor to improve passive self-regulation of pressure difference between the left and right atria, and reduce pump rotor over-excursion, was tested in vivo in a calf model to assess operational performance. Methods The CFTAH was implanted in a calf and run at various pump operating conditions including mean pump speeds from 2400 to 3600 RPM, sinusoidal speed modulations from 0 to 25%, and speed modulation rates from 80 to 120 B.M. It was also tested under various combinations of simulated high and low systemic vascular resistance and pulmonary vascular resistance via outlet graft clamping and administration of a Nitroprusside respectively. Results The CFTAH responded to all control inputs and ran as expected during the experiment. The head curves of the right and left pumps generated from measured pressures, measured right flow and calculated left flow, were consistent with in vitro data on this pump. The passive atrial pressure regulation performed well in the normal operating range, and there were no signs of excessive rotor axial displacement during extreme pressure excursions as had been seen in the previous versions of the pump. The left atrial pressure was unusually low throughout most of the experiment and we believe that this may have been due to partial blockage of the of the left inflow cuff proximal to the pressure line tap. This led to several left inlet suction conditions and extreme pressure conditions. Conclusion The replacement of the standard, single stack stator motor with the new dual stator stack motor resulted in better passive regulation of the pressure difference between the left and right atria. Also, the extreme pressure conditions resulting from left inlet suction events did not cause the pump's rotor to rub against the volute housing as had been seen in previous versions of the pump. Even though the self-regulation was acceptable, shifting of the regulation characteristic to increase the nominal LAP-RAP value will improve the regulation further, and this modification will be implemented prior to the next in vivo experiment.
- Published
- 2020
20. Mechanical Circulatory Support for Biventricular Heart Failure Using Advanced Ventricular Assist Device
- Author
-
J.H. Karimov, D. Horvath, Y. Kado, T. Miyamoto, B. Kuban, and K. Fukamachi
- Subjects
Pulmonary and Respiratory Medicine ,Aortic valve ,Transplantation ,Cardiac output ,medicine.medical_specialty ,business.industry ,medicine.medical_treatment ,Cardiogenic shock ,Atrial Pressure ,medicine.disease ,medicine.anatomical_structure ,Ventricular assist device ,Internal medicine ,Pulmonary valve ,Heart failure ,Cardiology ,Medicine ,Surgery ,Cardiology and Cardiovascular Medicine ,business ,Aortic valve regurgitation - Abstract
Purpose In patients with severe biventricular heart failure (HF) and cardiogenic shock, use of biventricular assist device (BVAD) can be a treatment of choice. We are developing an advanced ventricular assist device (AVAD) intended to serve as universal pump for left and/or right heart failure (Fig.1 A,B). The purpose of this initial in silico simulation study was to demonstrate that AVAD design can be suitable for biventricular support. Methods The virtual mock loop (VML) was developed (MATLAB; MathWorks®) to simulate hemodynamic parameters as they surge through the BVAD-supported systolic HF cardiovascular system. The AVAD used as in BVAD configuration was in 2 speeds (3400 rpm left, 2000 rpm right) to get comparable systemic flow and pressure outputs. LVAD support was adjusted to maintain 5.0 L/min total systemic flow. For BVAD, the added RVAD support was adjusted to maintain left and right atrial pressure (LAP-RAP) at 3-5 mm Hg. Results The BVAD performance was maintained very well for both left ventricular (L-AVAD) and right ventricular (R-AVAD) support within specified speed range (Fig1 C,D). L- AVAD speed of 3000 - 3500 rpm provided sufficient support for the case of severe left and right systolic heart failure, assuming there was no aortic valve regurgitation. At the simulated condition, with L-AVAD support, the aortic valve remains closed and the systemic pressure has reduced pulse. A stable hemodynamics were maintained. The atrial pressure difference (LAP-RAP) resulted to be sensitive to the right pump speed, though was balanced whenever there was any positive flow through the pulmonary valve. Introduction of R-AVAD support to the L-AVAD support caused the left atrial pressure to increase resulting in increased filling of the left ventricle and a corresponding increase in aortic pulsatility. Conclusion These initial in silico study demonstrated that use of the universal AVAD as BVAD supports cardiac output and arterial pressure in biventricular HF condition.
- Published
- 2020
21. Effect of Si content on microstructures, tensile properties, and creep properties in a cast Mg–6Al-0.4Mn–2Ca (wt.%) alloy
- Author
-
Chao Xu, Taiki Nakata, Shigeharu Kamado, T. Sakai, T. Miyamoto, and J. Liao
- Subjects
010302 applied physics ,Materials science ,Mechanical Engineering ,Alloy ,Fraction (chemistry) ,02 engineering and technology ,engineering.material ,021001 nanoscience & nanotechnology ,Condensed Matter Physics ,Microstructure ,01 natural sciences ,Creep ,Mechanics of Materials ,0103 physical sciences ,Ultimate tensile strength ,engineering ,General Materials Science ,Composite material ,0210 nano-technology ,Ductility - Abstract
Effect of Si content on microstructures, tensile properties, and creep properties in a gravity-cast Mg–6Al-0.4Mn–2Ca (wt.%, AMX6042) alloy has been investigated. High content of Si addition increases the ductility of the AMX6042 alloy without large loss of strengths; however, addition of Si over 0.6 wt.% decreases fraction of (Mg,Al)2Ca phases significantly. Moreover, such high content of Si promotes formation of Mg17Al12 phases, leading to poor creep properties. Although addition of Si tends to decrease fraction of (Mg,Al)2Ca phases and promote formation of Mg17Al12 phases, good creep properties could be kept up to 0.47 wt.% Si addition.
- Published
- 2020
22. Prospective Validation of Single Nucleotide Polymorphisms as Predictors of Rectal Toxicity Following Radiation Therapy for Prostate Cancer
- Author
-
S. Potter, H. Pleskow, David T. Miyamoto, Beow Y. Yeap, Anthony L. Zietman, Christine Olsen, S.P. Nisbet, Sophia C. Kamran, B.L. Silvia, R. Fisher, and Jason A. Efstathiou
- Subjects
Oncology ,Cancer Research ,medicine.medical_specialty ,Radiation ,business.industry ,medicine.medical_treatment ,Rectal toxicity ,Single-nucleotide polymorphism ,medicine.disease ,Radiation therapy ,Prostate cancer ,Internal medicine ,medicine ,Radiology, Nuclear Medicine and imaging ,business - Published
- 2019
23. Reply from Authors re: Ananya Choudhury, Peter J. Hoskin. Predictive Biomarkers for Muscle-invasive Bladder Cancer: The Search for the Holy Grail Continues. Eur Urol 2019;76:69–70
- Author
-
David T. Miyamoto, Jason A. Efstathiou, and Kent W. Mouw
- Subjects
Oncology ,medicine.medical_specialty ,Bladder cancer ,business.industry ,Urology ,Internal medicine ,medicine ,Muscle invasive ,Biomarker (medicine) ,business ,medicine.disease ,Holy Grail ,Predictive biomarker - Published
- 2019
24. The efficacy of secondary debulking surgery for recurrent ovarian, tubal and peritoneal cancer in low risk scores in the Tian model
- Author
-
Ryusuke Murakami, Kaoru Abiko, M. So, Shunsuke Kawahara, J. Hamanishi, Eiji Kondoh, Masaki Mandai, Akihito Horie, T. Miyamoto, Tsukasa Baba, and Ken Yamaguchi
- Subjects
medicine.medical_specialty ,Oncology ,Peritoneal cancer ,business.industry ,Obstetrics and Gynecology ,Medicine ,Debulking ,business ,Surgery - Published
- 2019
25. Molecular characterization of neuroendocrine-like bladder cancer
- Author
-
C-L. Wu, Marc A. Dall'Era, E. Davicioni, Jason A. Efstathiou, Yair Lotan, Ewan A. Gibb, Omar Y. Mian, Peter McL. Black, Jonathan L. Wright, L. Boormans, Samir Gupta, J. Batista Da Costa, Kent W. Mouw, Sia Daneshmand, M.S. van der Heijden, Trinity J. Bivalacqua, Petros Grivas, Yew-Huey Liu, Mohammed Alshalalfa, David T. Miyamoto, Roland Seiler, Badrinath R. Konety, B.W.G. Van Rhijn, H. Zarni Oo, and James Douglas
- Subjects
Bladder cancer ,business.industry ,Urology ,Cancer research ,Medicine ,business ,medicine.disease - Published
- 2019
26. Prospective Evaluation of a Digital RNA Circulating Tumor Cell Signature in Localized Prostate Cancer
- Author
-
David T. Miyamoto, Daniel A. Haber, John D. Milner, Shyamala Maheswaran, Mark Kalinich, Mehmet Toner, S. Potter, Anthony L. Zietman, J. Quilty, Jason A. Efstathiou, H. Pleskow, and R. Fisher
- Subjects
Cancer Research ,Prostate cancer ,Radiation ,Circulating tumor cell ,Oncology ,business.industry ,medicine ,Cancer research ,RNA ,Radiology, Nuclear Medicine and imaging ,medicine.disease ,business ,Prospective evaluation - Published
- 2018
27. Order–disorder transition of vacancies from the full- to the half-Heusler structure in Ni2−xMnSb alloys
- Author
-
K.R.A. Ziebeck, T. Miyamoto, Takeshi Kanomata, Y. Taguchi, Makoto Nagasako, and Ryosuke Kainuma
- Subjects
Crystallography ,Materials science ,Condensed matter physics ,Mechanics of Materials ,Mechanical Engineering ,Materials Chemistry ,Metals and Alloys ,Order (group theory) ,General Chemistry ,Crystal structure ,Contrast imaging - Abstract
The thermal transformations and crystal structures in the ordered bcc phases appearing in Ni 2− x MnSb alloys have been investigated. Thermo-analyses on NiMnSb( x = 1) show three λ-shaped peaks suggesting a magnetic and chemical ordering transitions at approximately 450, 865 and 965 °C. With decreasing x , the first and second peak temperatures gradually decrease, while the third one increases. By Z- contrast imaging technique, it was confirmed that the second peak corresponds to the order-disorder transition of vacancies from the L 2 1 to the C 1 b structure.
- Published
- 2015
28. The basolateral nucleus of the amygdala mediates caloric sugar preference over a non-caloric sweetener in mice
- Author
-
Tsuyoshi Shimura, Yasunobu Yasoshima, H. Yoshizawa, and T. Miyamoto
- Subjects
Male ,medicine.medical_specialty ,Calorie ,Sucrose ,Drinking ,Cell Count ,Amygdala ,Food Preferences ,chemistry.chemical_compound ,Saccharin ,Dietary Sucrose ,Internal medicine ,medicine ,Animals ,Food science ,Sugar ,Neurons ,Basolateral Nuclear Complex ,General Neuroscience ,Central Amygdaloid Nucleus ,digestive, oral, and skin physiology ,Caloric theory ,Immunohistochemistry ,Artificial Sweetener ,Mice, Inbred C57BL ,medicine.anatomical_structure ,Endocrinology ,chemistry ,Linear Models ,Analysis of variance ,Food Deprivation ,Psychology - Abstract
Neurobiological and genetic mechanisms underlying increased intake of and preference for nutritive sugars over non-nutritive sweeteners are not fully understood. We examined the roles of subnuclei of the amygdala in the shift in preference for a nutritive sugar. Food-deprived mice alternately received caloric sucrose (1.0 M) on odd-numbered training days and a non-caloric artificial sweetener (2.5 mM saccharin) on even-numbered training days. During training, mice with sham lesions of the basolateral (BLA) or central (CeA) nucleus of the amygdala increased their intake of 1.0 M sucrose, but not saccharin. Trained mice with sham lesions showed a significant shift in preference toward less concentrated sucrose (0.075 M) over the saccharin in a two-bottle choice test, although the mice showed an equivalent preference for these sweeteners before training. No increased intake of or preference for sucrose before and after the alternating training was observed in non-food-deprived mice. Excitotoxic lesions centered in the BLA impaired the increase in 1.0M sucrose intake and shift in preference toward 0.075 M sucrose over saccharin. Microlesions with iontophoretic excitotoxin injections into the CeA did not block the training-dependent changes. These results suggest that food-deprived animals selectively shift their preference for a caloric sugar over a non-caloric sweetener through the alternate consumption of caloric and non-caloric sweet substances. The present data also suggest that the BLA, but not CeA, plays a role in the selective shift in sweetener preference.
- Published
- 2015
29. Circulating Tumor Cell Clusters Are Oligoclonal Precursors of Breast Cancer Metastasis
- Author
-
Min Yu, Toshi Shioda, Shyamala Maheswaran, Nicola Aceto, Adam Pely, Charles P. Lin, Joel A. Spencer, Mehmet Toner, Ben S. Wittner, Brian W. Brannigan, Maria C. Donaldson, Daniel A. Haber, Amanda Engstrom, Aditya Bardia, Huili Zhu, Shannon L. Stott, David T. Miyamoto, Sridhar Ramaswamy, David T. Ting, and Ravi Kapur
- Subjects
Male ,Plakoglobin ,Breast Neoplasms ,Mice, SCID ,Biology ,General Biochemistry, Genetics and Molecular Biology ,Metastasis ,Mice ,Circulating tumor cell ,Breast cancer ,Single-cell analysis ,Mice, Inbred NOD ,Cell Line, Tumor ,medicine ,Animals ,Humans ,Neoplasm Metastasis ,Sequence Analysis, RNA ,Biochemistry, Genetics and Molecular Biology(all) ,Prostatic Neoplasms ,Cancer ,Neoplastic Cells, Circulating ,medicine.disease ,Primary tumor ,3. Good health ,Disease Models, Animal ,Cell culture ,Immunology ,Cancer research ,Female ,gamma Catenin ,Single-Cell Analysis - Abstract
SummaryCirculating tumor cell clusters (CTC clusters) are present in the blood of patients with cancer but their contribution to metastasis is not well defined. Using mouse models with tagged mammary tumors, we demonstrate that CTC clusters arise from oligoclonal tumor cell groupings and not from intravascular aggregation events. Although rare in the circulation compared with single CTCs, CTC clusters have 23- to 50-fold increased metastatic potential. In patients with breast cancer, single-cell resolution RNA sequencing of CTC clusters and single CTCs, matched within individual blood samples, identifies the cell junction component plakoglobin as highly differentially expressed. In mouse models, knockdown of plakoglobin abrogates CTC cluster formation and suppresses lung metastases. In breast cancer patients, both abundance of CTC clusters and high tumor plakoglobin levels denote adverse outcomes. Thus, CTC clusters are derived from multicellular groupings of primary tumor cells held together through plakoglobin-dependent intercellular adhesion, and though rare, they greatly contribute to the metastatic spread of cancer.
- Published
- 2014
- Full Text
- View/download PDF
30. Changes in parathyroid hormone-related protein concentrations in bovine milk from the early stage of lactation
- Author
-
Kazuhiro Kawai, T. Ohashi, Mamoru Ohnishi, Ken Onda, Reiichiro Sato, Hideharu Ochiai, Kazuyuki Kaneko, Yasunori Wada, T. Miyamoto, and K. Kazama
- Subjects
medicine.medical_specialty ,Bovine milk ,General Veterinary ,Parathyroid hormone-related protein ,food and beverages ,Biology ,fluids and secretions ,Animal science ,Milk yield ,medicine.anatomical_structure ,Endocrinology ,Internal medicine ,Lactation ,medicine ,Milk calcium ,Colostrum ,Animal Science and Zoology ,hormones, hormone substitutes, and hormone antagonists - Abstract
The concentration of parathyroid hormone-related protein (PTHrP) in the blood of healthy animals is extremely low. However, milk contains a relatively large amount of PTHrP, and the changes in its levels in the early stages of lactation in cows remain unclear. To understand the characteristics of parturient changes in milk PTHrP content and the biological implications thereof, changes in milk PTHrP concentrations were measured at 7 time intervals between parturition and 21 days postpartum in 8 primiparous and 8 multiparous Holstein cows. Based on these results, milk samples were collected from 47 primiparous and 66 multiparous Holstein cows at 3 days postpartum to investigate the relationship between milk PTHrP concentration and the variables of cow age, milk yield, and milk calcium concentration. Milk PTHrP concentration in both parity groups was found to be lowest on the day of parturition (primiparous, 3.1±0.5 nM and multiparous, 1.6±0.3 nM) but to significantly increase on day 14 of lactation in primiparous cows (6.2±0.8 nM) and day 7 of lactation in multiparous cows (4.1±0.2 nM). Comparison of the 2 groups revealed that milk PTHrP concentrations in primiparous cows were higher than those of multiparous cows in the first 3 days of lactation. Although a significant negative relationship was found between milk PTHrP concentration and both age ( r =−0.65) and milk calcium concentration ( r =−0.19) at 3 days postpartum, no significant correlation was found between milk PTHrP concentration and milk yield. The study thus identified 3 unique characteristics of milk PTHrP concentration in the early stages of lactation: milk PTHrP concentration is higher in primiparous than multiparous cows, milk PTHrP concentration is lower in colostrum than later milk, and the difference in milk PTHrP concentration between primiparous and multiparous cows at 3 days postpartum is more strongly influenced by age than milk yield.
- Published
- 2014
31. Integrated Gene Expression Score in Circulating Tumor Cells to Predict Treatment Response in Muscle-Invasive Bladder Cancer
- Author
-
J. A. Andrade Czapla, Daniel A. Haber, David T. Miyamoto, Shyamala Maheswaran, H. Pleskow, Jason A. Efstathiou, William L. Hwang, R.J. Lee, Anthony L. Zietman, Philip J. Saylor, R. Fisher, B.L. Silvia, David T. Ting, and Sophia C. Kamran
- Subjects
Cancer Research ,Treatment response ,Radiation ,Bladder cancer ,business.industry ,Muscle invasive ,medicine.disease ,Circulating tumor cell ,Oncology ,Gene expression ,medicine ,Cancer research ,Radiology, Nuclear Medicine and imaging ,business - Published
- 2019
32. Endovascular Repair Versus Surgical Repair for Japanese Patients With Ruptured Thoracic and Abdominal Aortic Aneurysms: A Nationwide Study
- Author
-
T. Miyamoto, Kunihiro Nishimura, R. Kyuragi, Toshihiro Nozato, Michikazu Nakai, Junichi Tazaki, Y. Kinoshita, Yasushi Sakata, Hitoshi Ogino, Tetsuo Yamaguchi, and Yoko Sumita
- Subjects
Surgical repair ,medicine.medical_specialty ,business.industry ,Medicine ,Surgery ,Cardiology and Cardiovascular Medicine ,business - Published
- 2019
33. Mechanical Circulatory Support for Biventricular Heart Failure Using Continuous-Flow Total Artificial Heart
- Author
-
David J. Horvath, T. Miyamoto, Nicole Byram, Joseph Adams, Jamshid H. Karimov, A. Polakowski, B. Kuban, Kiyotaka Fukamachi, Shiva Sale, and Y. Kado
- Subjects
Pulmonary and Respiratory Medicine ,Transplantation ,medicine.medical_specialty ,Cardiac output ,business.industry ,Cardiogenic shock ,Atrial Pressure ,Diastole ,Pulsatile flow ,Hemodynamics ,medicine.disease ,law.invention ,law ,Heart failure ,Artificial heart ,Internal medicine ,Cardiology ,medicine ,Surgery ,Cardiology and Cardiovascular Medicine ,business - Abstract
Purpose Biventricular assist device (BVAD) implantation is the treatment of choice in patients with severe biventricular heart failure (BHF) and cardiogenic shock . We previously developed a miniaturized continuous flow double-ended centrifugal pump intended for total artificial heart implant (CFTAH). The purpose of this initial in vitro study was to prove that scaled down CFTAH can be suitable for biventricular support. Methods The CFTAH was tested in BVAD configuration at 2 pump speeds (4500 and 6000 rpm) on a pulsatile mock loop with two pneumatic ventricles that simulated normal and heart failure conditions (moderate and severe) by adjusting the systolic and diastolic drive pressures to simulate hemodynamics of the failing biventricular function. Results The BVAD performance was maintained very well for both atrial and ventricular cannulation within the 4500 - 6000 rpm range. A stable hemodynamics were maintained, and the pump's self-regulating performance was confirmed with the most of atrial pressure difference (LAP-RAP) falling within ±5-15 mm Hg in (Mod.) and severe (Sev.) right (RHF) and left HF (LHF) conditions. Left and right pump flows (LPF and RPF) and total flow (TF) increased as the BVAD speed was increased (Figure). The TF was higher than LPF and RPF due to output from the native ventricles, and the LPF was higher than RPF with pump speed of 6,000 rpm, but the TF appeared balanced due to larger native right ventricular output vs. native left ventricle with given condition. Conclusion These initial in vitro study demonstrated that use of the CFTAH as BVAD supports cardiac output and arterial pressure in BHF conditions. In vivo evaluation of this technology is currently pending.
- Published
- 2019
34. Evaluation of New Left Ventricular Assist Device for Transapical Insertion Using Virtual Mock Loop Model
- Author
-
A. Polakowski, W.A. Smith, Y. Kado, Jamshid H. Karimov, T. Miyamoto, Kiyotaka Fukamachi, Nicole Byram, David J. Horvath, Joseph Adams, and Raymond Dessoffy
- Subjects
Pulmonary and Respiratory Medicine ,Transplantation ,medicine.medical_specialty ,business.industry ,medicine.medical_treatment ,Diastole ,Hemodynamics ,medicine.disease ,medicine.anatomical_structure ,Ventricle ,Heart failure ,Ventricular assist device ,Internal medicine ,medicine.artery ,Circulatory system ,Pulmonary artery ,medicine ,Aortic pressure ,Cardiology ,Surgery ,Cardiology and Cardiovascular Medicine ,business - Abstract
Purpose The aim of this study was to assess a new pump's performance and function by using a virtual mock loop (VML) system for device characterization and mapping. Methods We are developing a novel miniaturized left ventricle assist device (LVAD) configured for transapical insertion (Perfusions Solutions Inc., South Euclid, OH). The results of pump testing in the laboratory, such as pressure-flow performance curves, were used for the analysis of its function as an LVAD. The VML system was programmed to mimic various types of heart failure and provide hemodynamic pressure values before and after activation of LVAD. The circulatory conditions of the VML system were systolic heart failure (SHF), diastolic HF (DHF), and both systolic and diastolic HF (BHF). Results Before and after pump activation with SHF condition and with a pump speed of 14000 RPM, aortic pressure (AoP) increased from 71/50 to 99/97 mm Hg, pulmonary artery pressure (PAP) changed from 44/36 to 44/33 mm Hg, mean left atrium pressure (mLAP) decreased from 25 to 18 mm Hg, mean right atrium pressure (mRAP) increased from 7 to 10 mm Hg; with DHF, AoP changed from 116/81 to 129/113 mm Hg, PAP was 45/34 to 45/31 mm Hg, mLAP was 18 to 15 mm Hg, mRAP was 10 to 12 mm Hg; with BHF, AoP was 65/46 to 98/96 mm Hg, PAP was 44/36 to 45/33 mm Hg, mLAP was 26 to 19 mm Hg, mRAP was 7 to 10 mm Hg. (Figure A; pressure-volume curve with BHF, B; pressure curve with BHF without LVAD, 14000 RPM and 16000 RPM of the pump speed) Conclusion Due to the test results from the VML system, the new LVAD for transapical insertion could have the ability enough to ease symptoms of the patients with various types of heart failure based on results from VML system.
- Published
- 2019
35. Development of Continuous-Flow Total Artificial Heart for Use in Infants
- Author
-
T. Miyamoto, David J. Horvath, Nicole Byram, Hani K. Najm, B. Kuban, Kiyotaka Fukamachi, Munir Ahmad, A. Polakowski, Y. Kado, Robert W. Stewart, Elizabeth V. Saarel, and Jamshid H. Karimov
- Subjects
Pulmonary and Respiratory Medicine ,Heart transplantation ,Transplantation ,Heart disease ,business.industry ,Continuous flow ,medicine.medical_treatment ,Hemodynamics ,Blood volume ,medicine.disease ,law.invention ,Blood pump ,law ,Artificial heart ,Circulatory system ,medicine ,Surgery ,Cardiology and Cardiovascular Medicine ,business ,Biomedical engineering - Abstract
Purpose Heart transplantation in infants and children is an accepted therapy for congenital heart disease, but donor organ availability remains unstable. Mechanical circulatory support is another standard option, but there is a lack of implantable devices due to size and functional range. The purpose of this study was to evaluate in vivo performance of the initial prototype of an infant continuous-flow total artificial heart (I-CFTAH) with one motor and one rotating assembly supported by a hydrodynamic bearing. Methods The I-CFTAH was designed to cover a range of 3 kg infant to 9 kg child (flange diameter - 26.9 mm; length - 44 mm), with nominal design point was matched to a 6 kg child, requiring 1.0 L/min of flow. I-CFTAH was tested using in silico virtual simulation mock loop (VML; MATLAB; MathWorks®) and simulated the hemodynamics as they surge through the system implanted with blood pump (run at 0.5 L/min for 3 kg infant). Lumped-parameter model including systemic/pulmonary circulation, values for impedance, beat rate, and blood volume was used. Results The in silico experiments showed intended performance of scaled down pump (left and right pump flows - 0.5 L/min at 4380 RPM). The difference between the left and right atrial pressures was maintained within ± 5-15 mm Hg. Simulation of I-CFTAH was successfully performed and allowed creating arterial pulsation with this device. Conclusion The present simulation-based approach showed feasibility of I-CFTAH design. The I-CFTAH met the proposed requirements for self-regulation, performance and pulse modulation. Further in vitro validation and in vivo implantation will be necessary to explore this technology in more detail.
- Published
- 2019
36. LEFT ATRIAL ASSIST DEVICE: A NEW DEVICE TO TREAT PATIENTS WITH HEART FAILURE WITH PRESERVED EJECTION FRACTION
- Author
-
Yuichiro Kado, David J. Horvath, Joseph Adams, Barry D. Kuban, Jamshid H. Karimov, Randall C. Starling, T. Miyamoto, Nicole Byram, and Kiyotaka Fukamachi
- Subjects
medicine.medical_specialty ,Ejection fraction ,business.industry ,Left atrium ,Diastole ,medicine.disease ,medicine.anatomical_structure ,Left atrial ,Ventricle ,Heart failure ,Internal medicine ,cardiovascular system ,medicine ,Cardiology ,New device ,cardiovascular diseases ,Cardiology and Cardiovascular Medicine ,business ,Heart failure with preserved ejection fraction - Abstract
Many patients with heart failure have preserved ejection fraction but also diastolic dysfunction, with no effective therapy. We are developing a new pump (Left Atrial Assist Device, LAAD) implanted at the mitral position to pump blood from the left atrium to fill the left ventricle properly. The
- Published
- 2019
37. Construction of the SCRIT electron scattering facility at the RIKEN RI Beam Factory
- Author
-
Y. Miyashita, Y. Haraguchi, Tatsuya Amagai, K. Kurita, A. Enomoto, M. Hara, A. Enokizono, R. Kitazawa, K. Yanagi, Tadaaki Tamae, Mamoru Togasaki, K. Koizumi, Shin-ichi Ichikawa, Toshimi Suda, Hiroki Takehara, Tatsuya Adachi, R. Ogawara, Tsuyoshi Ohnishi, Takashi Kikuchi, Toshitada Hori, Y. Shimakura, T. Miyamoto, Takayuki Yamaguchi, Masanori Wakasugi, S. Tamaki, and S. Wang
- Subjects
Physics ,Novel technique ,Nuclear and High Energy Physics ,Electron ,Ion trapping ,Ion ,Nuclear physics ,Electron storage ,Cathode ray ,Physics::Accelerator Physics ,Atomic physics ,Instrumentation ,Microtron ,Electron scattering - Abstract
The SCRIT electron scattering facility, aiming at electron scattering off short-lived unstable nuclei, has been constructed at the RIKEN RI Beam Factory. This facility consists of a racetrack microtron (RTM), an electron storage ring (SR2) equipped with the SCRIT system, and a low-energy RI separator (ERIS). SCRIT (self-confining radioactive isotope ion targeting) is a novel technique to form internal targets in an electron storage ring. Experiments for evaluating performance of the SCRIT system have been carried out using the stable 133Cs1+ beam and the 132Xe1+ beam supplied from ERIS. Target ions were successfully trapped in the SCRIT system with 90% efficiency at a 250 mA electron beam current, and luminosity exceeding 10 26 /(cm2 s) was maintained for more than 1 s. Electrons elastically scattered from the target ions were successfully measured. Applicability of the SCRIT system to electron scattering for unstable nuclei has been established in experiments.
- Published
- 2013
38. Estimation of regional stress state and Young’s modulus by back analysis of mining-induced deformation
- Author
-
Jun-ichi Kodama, Yoshiaki Fujii, Katsuhiko Kaneko, Satoru Kawasaki, T. Miyamoto, and Paul C. Hagan
- Subjects
Gravity (chemistry) ,Strain (chemistry) ,Modulus ,Young's modulus ,Geotechnical Engineering and Engineering Geology ,Geodesy ,Finite element method ,Displacement (vector) ,Stress (mechanics) ,symbols.namesake ,symbols ,Geotechnical engineering ,Deformation (engineering) ,Geology - Abstract
A method to evaluate regional stress state and Young’s modulus by analyzing the mining-induced deformation of ground is proposed. The effect of changes in regional strain state due to tectonic plate motion can be accounted for using the proposed method. Mining-induced deformation can manifest itself as changes in ground surface geometry resulting from mining activity. There are three underlying factors that can contribute to the deformation, these being: displacement induced by the effect of gravity; displacement induced by the effect of horizontal regional strain; and, incremental change in the horizontal regional strain. Both regional strain and Young’s modulus can be simultaneously estimated, because the displacement induced by the regional strain is independent of the Young’s modulus and the displacement induced by the gravity is inversely proportional to the Young’s modulus. The relative displacement arising from the mining excavation at the Torigatayama limestone mine in Japan has been measured by GPS. Both the regional stress state and Young’s modulus were estimated by back analysis of the relative displacement using a 3-D finite element method. It was shown that back analysis based on changes in distance between the measurement points provides a more reliable estimation than that could be achieved based on the direct relative displacement.
- Published
- 2013
39. Phase equilibria in the Ni–Mn–In alloy system
- Author
-
Makoto Nagasako, T. Miyamoto, and Ryosuke Kainuma
- Subjects
Chemistry ,Mechanical Engineering ,Diffusion ,Alloy ,Metals and Alloys ,engineering.material ,Crystallography ,Ferromagnetism ,Magnetic shape-memory alloy ,Mechanics of Materials ,Martensite ,Phase (matter) ,Diffusionless transformation ,Materials Chemistry ,engineering ,Phase diagram - Abstract
Phase equilibria at 700 and 850 °C, critical temperatures of B 2/ L 2 1 order–disorder transformation and martensitic and ferromagnetic phase regions at room temperature in the Ni–Mn–In system were determined mainly by diffusion triple method using a two-stage diffusion couple technique. It was confirmed that a single phase region of the β phase at both 700 and 850 °C exists in a wide composition range along the NiMn–NiIn section and that the L 2 1 ordered phase region appears in the vicinity of Ni 2 MnIn in the temperature region below about 800 °C. The composition lines, iso- M s and iso- T FM , possessing the M s and T C temperatures at room temperature, respectively, were successfully estimated and the coincidence between the iso- M s and iso- T FM was confirmed in the composition region from 10 to 20 at.% In in the β-phase region.
- Published
- 2013
40. Optimal coherence tomography as a tool to evaluate retinal changes in idiopathic REM sleep behavior disorders and Parkinson disease
- Author
-
T. Miyamoto
- Subjects
chemistry.chemical_compound ,Neurology ,chemistry ,business.industry ,Sleep behavior ,Medicine ,Retinal ,Neurology (clinical) ,Tomography ,Coherence (statistics) ,business ,Neuroscience - Published
- 2017
41. OC-0049: Genomic profiling of muscle invasive bladder cancer to predict response to chemoradiation therapy
- Author
-
Jason A. Efstathiou, Ewan A. Gibb, Michael Drumm, Jonathan Lehrer, Chin-Lee Wu, Hussam Al-Deen Ashab, E. Davicioni, David T. Miyamoto, William U. Shipley, Yang Liu, Kent W. Mouw, Kaye Ong, M. Du Plessis, and N. Erho
- Subjects
Bladder cancer ,Genomic profiling ,Oncology ,business.industry ,Muscle invasive ,Cancer research ,medicine ,Radiology, Nuclear Medicine and imaging ,Hematology ,medicine.disease ,business - Published
- 2018
42. Phase stability and magnetic properties of Ni50Mn50−xInx Heusler-type alloys
- Author
-
T. Miyamoto, Rie Y. Umetsu, Kiyohito Ishida, Ryosuke Kainuma, Takeshi Kanomata, and Wataru Ito
- Subjects
Curie–Weiss law ,Materials science ,Magnetic moment ,Condensed matter physics ,Phase stability ,Mechanical Engineering ,Metals and Alloys ,Type (model theory) ,Condensed Matter Physics ,Magnetic shape-memory alloy ,Mechanics of Materials ,Curie temperature ,General Materials Science ,Ternary operation ,Spontaneous magnetization - Abstract
The order–disorder transformation and the magnetic properties of Heusler-type Ni50Mn50−xInx ternary alloys were investigated. The B2/L21 order–disorder transformation temperatures are detected at about 800–1100 K. In the alloys with the L21 structure, while the spontaneous magnetization at 4.2 K monotonically decreases with increasing x, the Curie temperature is almost constant with x ⩽ 25 and decreases linearly with x > 25. This unique behavior is qualitatively explained by the concept of local magnetic moment of Mn atoms.
- Published
- 2010
43. The prospective study of nigrostriatal dopaminergic function using by striatal dopamine transporter imaging (FMT/PET) in patients with idiopathic REM sleep behavior disorder
- Author
-
M. Miyamoto and T. Miyamoto
- Subjects
Striatal dopamine ,business.industry ,Dopaminergic ,Medicine ,In patient ,Transporter ,General Medicine ,business ,Prospective cohort study ,medicine.disease ,REM sleep behavior disorder ,Neuroscience ,Function (biology) - Published
- 2017
44. Large asymptomatic pneumocephalus developing years after middle cranial fossa surgery—A case report
- Author
-
Ilka C. Naumann and Richard T. Miyamoto
- Subjects
Surgical resection ,medicine.medical_specialty ,Time Factors ,Middle cranial fossa ,Asymptomatic ,Medical Records ,Meningioma ,Postoperative Complications ,Pneumocephalus ,Temporal bone ,Meningeal Neoplasms ,medicine ,Humans ,Cranial Fossa, Middle ,medicine.diagnostic_test ,business.industry ,Magnetic resonance imaging ,General Medicine ,Middle Aged ,medicine.disease ,Magnetic Resonance Imaging ,Surgery ,medicine.anatomical_structure ,Otorhinolaryngology ,Female ,Neoplasm Recurrence, Local ,medicine.symptom ,business ,Meningitis - Abstract
Whereas acute pneumocephalus has been well characterized in the literature: typically seen postoperatively after neurosurgical and neurotological procedures, a chronic pneumocele developing several years after surgery is highly unusual. Most otogenic pneumocephali develop in an acute or subacute fashion, presenting with focal neurological symptoms, headache or signs of meningitis secondary to translocation of bacteria into the cavity. We describe a patient with a supra-auricular soft-tissue swelling as the only presenting symptom of a large chronic epidural pneumocele with extension into the extracranial subcutaneous tissues. It presented several years after surgical resection of a meningioma that involved the temporal bone.
- Published
- 2009
45. Ductile fracture behavior of 5052 aluminum alloy sheet under cyclic plastic deformation at room temperature
- Author
-
Tetsuya Yagami, T. Miyamoto, and Ken-ichi Manabe
- Subjects
Materials science ,Bending (metalworking) ,Metallurgy ,Metals and Alloys ,Fractography ,Industrial and Manufacturing Engineering ,Computer Science Applications ,Plastic bending ,Modeling and Simulation ,Ceramics and Composites ,Formability ,Composite material ,Deformation (engineering) ,Ductility ,Necking ,Tensile testing - Abstract
Ductile fracture behavior of a 5052 aluminum alloy sheet undergoing cyclic plastic deformation is investigated in order to clarify the effect of cyclic plastic deformation on formability enhancement in incremental stretch sheet forming at room temperature. In the incremental forming, formability markedly increases owing to strain distribution and accumulation effects. The former effect is activated when the deformation region expands along tool paths. Thus, localization of deformation, which leads to necking or fracturing, can be prevented. On the other hand, local strain is accumulated without fracturing when a blank sheet is repeatedly subjected to out-of-plane deformation at the same position. In this paper, the effect of the strain accumulation due to cyclic deformation generated by bending and unbending is primarily focused on to discuss the effect on deformability. To apply cyclic plastic straining to the specimen, a cyclic stretch-bending test was adopted. A cyclic tensile test was also conducted for larger bending curvature. The experimental results show that cyclic bending–unbending affects the ductility of sheet metals. The fractography obtained by scanning electric microscopy also indicates that fewer and smaller voids are observed particularly on bending the inner side than on the outer side.
- Published
- 2009
46. Cochlear implantation for cochlear dysplasia
- Author
-
Karen Iler Kirk, R. Christopher Miyamoto, Richard T. Miyamoto, and John T. McElveen
- Subjects
education.field_of_study ,medicine.medical_specialty ,Speech perception ,Profound sensorineural hearing loss ,business.industry ,Incidence (epidemiology) ,fungi ,Population ,food and beverages ,Connective tissue ,Audiology ,medicine.disease ,Surgery ,medicine.anatomical_structure ,Otorhinolaryngology ,Dysplasia ,otorhinolaryngologic diseases ,Deformity ,Medicine ,sense organs ,medicine.symptom ,business ,education ,Cochlear implantation - Abstract
Profound sensorineural hearing loss secondary to cochlear dysplasia presents a number of surgical challenges during cochlear implantation. The standard transmastoid-facial recess approach can be performed in the majority of cases. In cases of common cavity deformity, the transmastoid labyrinthotomy approach has a number of advantages. A high incidence of CSF gushers occurs in this population but can be managed by creating a small cochleostomy and tightly sealing the cochleostomy with connective tissue. Acceptable postoperative speech perception results can be expected.
- Published
- 2005
47. Visual attention, behavioral inhibition and speech/language outcomes in deaf children with cochlear implants
- Author
-
Richard T. Miyamoto, David B. Pisoni, David L. Horn, and Rebecca A. O. Davis
- Subjects
medicine.medical_specialty ,Vocabulary ,medicine.medical_treatment ,media_common.quotation_subject ,Outcome measures ,General Medicine ,Audiology ,Executive functions ,Article ,Test (assessment) ,Behavioral response ,Cochlear implant ,otorhinolaryngologic diseases ,medicine ,Visual attention ,Behavioral inhibition ,Psychology ,media_common - Abstract
We investigated relations between sustained visual attention, behavioral inhibition skills, and speech–language outcomes in prelingually deaf children who use cochlear implants (CIs) using two computerized continuous performance tasks (CPTs). One test measured their ability to sustain visual attention to a string of numbers and another test measured their ability to delay a behavioral response. Performance on latter task was related to postimplant scores on tests of vocabulary knowledge, language skills, and speech intelligibility. We conclude that behavioral inhibition skills of prelingually deaf children are related to several audiological outcome measures in deaf children with CIs. Our findings suggest that further investigation is warranted into executive functions and subvocal rehearsal skills of deaf children with CIs.
- Published
- 2004
48. Preparation of melt-textured YBa2Cu3O7−δ bulk with CeO2 additions and their superconducting properties
- Author
-
T. Miyamoto, Uichiro Mizutani, A. Takagi, and Hiroshi Ikuta
- Subjects
Superconductivity ,Materials science ,Scanning electron microscope ,Analytical chemistry ,Energy Engineering and Power Technology ,Condensed Matter Physics ,Microstructure ,Homogeneous distribution ,Electronic, Optical and Magnetic Materials ,Matrix (chemical analysis) ,Nuclear magnetic resonance ,Cuprate ,Electrical and Electronic Engineering ,Current density ,Type-II superconductor - Abstract
The c-axis oriented YBa 2 Cu 3 O 7-δ (Y123) bulk superconductors with up to 2.0 wt.% CeO 2 and 18 mm in diameter were prepared by the so-called MMTG process. The critical current density J C significantly increased with 1.0 or above wt.% CeO 2 additions. The sample with 2.0 wt.% CeO 2 additions exhibited a J C of 330,000 A/cm 2 at 35 K and 0 T, when the field was applied parallel to the c-axis of the sample. The maximum of the trapped magnetic field reached 4.2 T at 30 K at the center of the sample surface, which is more than 10 times larger than conventional Nd-Fe-B permanent magnets. Particles of a Ce-Ba compound, whose existence was identified from the observations using a scanning electron microscope, are not distributed uniformly in the Y123 matrix. This high trapped magnetic field of the sample with 2.0 wt.% CeO 2 additions can be explained in terms of a more homogeneous distribution of fine Y 2 BaCuO 5 (Y211) particles in the Y123 matrix compared with the CeO 2 -free sample.
- Published
- 2004
49. Scaling law of fine scale eddies in turbulent channel flows up to Reτ=800
- Author
-
Toshio Miyauchi, Shin-Jeong Kang, T. Miyamoto, Mamoru Tanahashi, and S. Shiokawa
- Subjects
Fluid Flow and Transfer Processes ,Physics ,Homogeneous isotropic turbulence ,Scale (ratio) ,Turbulence ,Mechanical Engineering ,Direct numerical simulation ,Mechanics ,Strain rate ,Condensed Matter Physics ,Pipe flow ,Physics::Fluid Dynamics ,Classical mechanics ,Eddy ,Turbulence kinetic energy - Abstract
To clarify the scaling law of fine scale eddies in turbulent channel flows, direct numerical simulations are conducted for Re τ =180, 400 and 800. The diameter and the maximum azimuthal velocity of coherent fine scale eddies can be scaled by Kolmogorov microscale ( η ) and Kolmogorov velocity ( u k ). The most expected diameter and maximum azimuthal velocity are 8–10 η and 1.2–2.0 u k , respectively. Near the wall, the most expected diameter increases to 10 η from 8 η and the most expected maximum azimuthal velocity increases to 2.0 u k from 1.2 u k . Strain rates at the center of the coherent fine scale eddies are small compared with the mean strain rate of the whole flow field. The strain rates acting on the fine scale eddies away from the wall coincide with those in homogeneous isotropic turbulence and turbulent mixing layer. However, relatively large strain rates are acting on the near-wall coherent fine scale eddies. The most expected angle between the intermediate eigenvector and the rotating axis of the fine scale eddy is about 15–17°, which is independent of the turbulent flow fields. The probability that coherent fine scale eddies exist in low-speed streaks is higher than that in high-speed streaks. Large scale structures of wall turbulence are visualized by showing spatial distributions of central axes of coherent fine scale eddies.
- Published
- 2004
50. Quantification of nitrogen profiles in HfSiON films for gate dielectrics
- Author
-
T. Yamamoto, T. Miyamoto, and A. Karen
- Subjects
Gate dielectric ,Analytical chemistry ,General Physics and Astronomy ,chemistry.chemical_element ,Surfaces and Interfaces ,General Chemistry ,Dielectric ,Condensed Matter Physics ,Nitrogen ,Surfaces, Coatings and Films ,Ion ,Secondary ion mass spectrometry ,X-ray photoelectron spectroscopy ,chemistry ,Thin film ,High-κ dielectric - Abstract
We have performed a study to optimize the measurement conditions for SIMS analysis of thin HfSiON films with various nitrogen concentrations, prepared by post-nitridation of HfSiO x . In this study of 2.5 nm thick HfSiON films, we have measured SIMS depth profiles of oxygen and nitrogen under 500 eV Cs + bombardment at approximately 70° from the surface normal, similar to those obtained by HR-RBS. Under the same measurement conditions, good correlation between the estimated nitrogen concentration from XPS and the CsN + secondary ion intensity by SIMS has been observed for nitrogen concentrations less than 15%.
- Published
- 2004
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.